The pathophysiology of erectile dysfunction is complex, and may involve either single or multiple etiologies which may lead to cellular or tissue abnormalities. 1, 2 Multiple treatment modalities have been proposed and attempted, both experimentally and clinically, over the years. 3 Silicone rigid prostheses were popularized in the 1970s and have been used widely. 4, 5 However, biocompatibility and biomechanical issues have been a problem in selected patients. 6, 7 Vascular reconstructive techniques to restore erectile function have been performed for several decades. 8, 9 Although the overall outcome of vascular reconstruction for erectile dysfunction has been gradually improving due to the evolution of microsurgical techniques, operative complications, such as infection, vessel occlusion and overall operative morbidity are not negligible. 8, 9 Intracorporal, intraurethral, topical and oral pharmacologic agents have been used widely in patients with erectile dysfunction: however, the treatment is acute, and limited only to each episode of sexual stimulation.
10±13
Reconstruction of normal erectile tissue using autologous cells, derived from the patient's own body, may be preferable. Our laboratory has applied the principles of cell transplantation, materials science and engineering in an effort to develop biological substitutes which would restore and maintain normal function. Cell transplantation has been proposed for the replacement of a variety of tissues, including skin, pancreas and liver. However, the concept of urologic associated cell transplantation had not been formally approached in the laboratory setting until earlier this decade. We proposed an approach to urologic tissue regeneration which involved patching isolated cells to support structures which would have a suitable surface chemistry for guiding cell reorganization and growth.
14±18
It is known from previous studies that arti®cial permanent support structures are lithogenic (Te¯on, silicone). 16 Investigators have tried permanent homograft or heterograft support structures such as dura; however these contract with time and are problematic in a clinical setting. A variety of synthetic polymers, both degradable and non-degradable, have been utilized to fabricate tissue engineering matrices. 19 Synthetic polymers can be manufactured reproducibly and can be designed to exhibit the necessary mechanical properties. 20 Among synthetic materials, resorbable polymers are preferable because permanent polymers carry the risk of infection, calci®cation, and unfavorable connective tissue response. Polymers of lactic and glycolic acid have been extensively utilized to fabricate tissue engineering matrices. 20 These polymers have many desirable features; they are biocompatible, processable, and biodegradable. Degradation occurs by hydrolysis and the time sequence can be varied from weeks to over a year by manipulating the ratio of monomers and by varying the processing conditions. These polymers can be readily formed into a variety of structures, including small diameter ®bers and porous ®lms.
The porosity, pore size distribution and continuity dictate the interaction of the biomaterials and transplanted cells with the host tissue. Fibrovascular tissue will invade a device if the pores are larger than approximately 10 mm, and the rate of invasion will increase with the pore size and total porosity of a device. 21, 22 This process results in the formation of a capillary network in the developing tissue. 22 Vascularization of the engineered tissue may be required to meet the metabolic requirements of the tissue and to integrate it with the surrounding host.
The direction which we have followed to engineer urologic tissue involves the use of both synthetic (polyglycolic and/or poly-lactic acid, alginate) and natural (bladder submucosa, intestinal submucosa, peritoneum, and reconstituted collagen) biodegradable materials, which act as cell delivery vehicles.
Reconstruction of corporal smooth muscle
One of the major components of the phallus is corporal smooth muscle. The creation of autologous functional and structural corporal tissue de novo would be bene®cial in some patients with erectile dysfunction. To achieve this goal, our efforts have been directed toward creating human corpus cavernosal tissue.
Initial experiments were performed in our tissue engineering laboratory in order to determine the feasibility of creating corporal smooth muscle in vivo using cultured human corporal smooth muscle cells seeded onto biodegradable polymers. 23 Primary normal human corpus cavernosal smooth muscle cells were isolated from normal young adult patients after informed consent during routine penile surgery. Muscle cells were maintained in culture, seeded onto biodegradable polymer scaffolds, and implanted subcutaneously in athymic mice. Implants were retrieved at 7, 14 and 24 days after surgery for analyses. Corporal smooth muscle tissue was identi®ed grossly, and histologically. Intact smooth muscle cell multilayers were observed growing along the surface of the polymers throughout all time points. Early vascular ingrowth at the periphery of the implants was evident by 7 days. By 24 days, there was evidence of polymer degradation. Smooth muscle phenotype was con®rmed immunocytochemically and by Western blot analyses with antibodies to alpha-smooth muscle actin. This study provided the ®rst evidence that cultured human corporal smooth muscle cells may be used in conjunction with biodegradable polymers to create corpus cavernosum smooth muscle de novo.
Endothelial cell expansion and characterization
In order to engineer functional corpus cavernosum, both smooth muscle and sinusoidal endothelial cells are essential. However, penile sinusoidal endothelial cells had not been extensively cultured in the past, and had not been fully characterized. A method of isolation and expansion of sinusoidal endothelial cells from corpora cavernosa was devised, and cell function and gene expression were characterized.
Corpus cavernosum tissue was digested with collagenase type 2, and the cells were grown in culture. The endothelial cells were isolated from primary culture by magnetic beads coated with anti bovine E-selectin antibodies. To verify the phenotype, endothelial cells were immuno-stained with antibodies that recognize endothelial cellspeci®c markers. To test if they express functional receptors for vascular endothelial growth factor (VEGF), cross-linking of 125 I-VEGF 165 to the cells was performed, and 125 I-VEGF 165 /VEGF-receptor complexes were analyzed by SDS-PAGE and autoradiography. The mitogenic response of the cells to increasing concentrations of VEGF and basic ®bro-blast growth factor (bFGF) was tested, as well as their ability to form capillaries in three-dimensional collagen gels.
Immuno-isolated endothelial cells from corpus cavernosum had endothelial cell-like morphology and formed a cobblestone-like structure when they reached con¯uence. The cells were positively stained with anti E-selectin, Factor VIII and Flk-1 antibodies, indicating their endothelial origin. Cross-linking of These results demonstrate that immuno-isolation is a reliable method to obtain endothelial cells from corpus cavernosum. Cultured endothelial cells express speci®c markers, have an endothelial morphology and express functional VEGF receptors. The cells proliferate in response to endothelial cell growth factors and they have the capability to form a three-dimensional capillary network. Thus, corpus cavernosum-derived endothelial cells may be obtained from a biopsy, grown in culture, and expanded, while retaining their phenotypic characteristics.
Engineering of corporal smooth muscle and endothelium in vivo
In a subsequent study, we investigated the possibility of developing human corporal tissue in vivo by combining smooth muscle and endothelial cells. 24 Primary normal human corpus cavernosal smooth muscle cells and ECV 304 human endothelial cells were seeded on biodegradable polymers at concentrations of 20Â10 6 At retrieval all polymer scaffolds seeded with cells had formed instinct tissue structures and maintained their pre-implantation size. The control scaffolds without cells had decreased in size with increasing time. Histologically, all of the retrieved polymers seeded with corporal smooth muscle and endothelial cells showed the survival of the implanted cells. The presence of penetrating native vasculature was observed ®ve days after implantation. The formation of multilayered strips of smooth muscle adjacent to endothelium was evident seven days after implantation. Increased smooth muscle organization and accumulation of endothelium lining the luminal structures were evident 14 days after implantation. A well organized construct, consisting of smooth muscle and endothelial cells, was noted at 28 and 42 days after implantation (Figure 1) . A marked degradation of the polymer ®bers was observed by 28 days. There was no evidence of tissue formation in the controls (polymers without cells).
Immunocytochemical analyses using anti-vWF (identifying native vasculature) and anti-pancytokeratins (identifying ECV 304 endothelial cells) distinguished the origin of the vascular structures in each of the constructs. Anti-vWF antibodies stained the native vessels positively, but failed to stain the implanted endothelial cells and reconstituted vascular structures. In contrast, anti-pancytokeratin antibodies identi®ed the implanted endothelial cells and the reconstituted vessels, but did not stain the native vascular structures. Antialpha actin antibodies con®rmed the smooth muscle phenotype. Smooth muscle ®bers were progressively organized with time.
Computer assisted quantitative morphometric analysis of the retrieved specimens showed that the tissue was composed of 31.2 AE 1.6% smooth muscle and 16.4 AE 1.5% endothelium. These results were consistent throughout the study. The smooth muscle to endothelial tissue ratio was 1.98 AE 0.16 : 1. This ratio was approximately equivalent to the ratio of smooth muscle and endothelial cell seeding prior to implantation (2 : 1).
These experiments showed that human corporal smooth muscle cells and endothelial cells seeded on biodegradable polymer scaffolds are able to form vascularized cavernosal muscle when implanted in vivo. This was the ®rst demonstration in tissue engineering wherein capillary formation is facilitated by the addition of endothelial cells for the formation of composite tissue in vivo. Endothelial cells are able to act in concert with the native vasculature. The results of these studies suggested that the creation of well vascularized autologous corporal-like tissue, consisting of smooth muscle and endothelial cells, may be possible.
Tissue engineering of structural corporal tissue
The aim of phallic reconstruction is to achieve structurally and functionally normal genitalia. We had shown that human cavernosal smooth muscle and endothelial cells seeded on polymers would form tissue composed of corporal cells when Tissue engineering for erectile dysfunction A Atala implanted in vivo. However, corporal tissue structurally identical to the native corpus cavernosum was not achieved, due to the type of polymers used. Therefore, we developed a naturally derived acellular corporal tissue matrix that possesses the same architecture as native corpora. In this study, we explored the feasibility of developing corporal tissue, consisting of human cavernosal smooth muscle and endothelial cells in vivo, using an acellular corporal tissue matrix as a cell delivery vehicle.
Acellular corporal tissue matrices were derived from processed donor rabbit corpora, using cell lysis techniques. Primary human corpus cavernosal smooth muscle and endothelial cells, obtained from routine penile surgeries, were seeded on the acellular matrices at a concentration of 30Â10 6 cells/ml and 3Â10 6 cells/ml, respectively ( Figure 2) . A total of 60 tissue matrices seeded with cells and 20 control matrices without cells were implanted in the subcutaneous space of 20 athymic mice. An additional 36 acellular tissue matrices seeded with cells were grown in culture for 1, 2, 3 and 4 weeks. Scanning electron microscopy was performed to con®rm cell attachments to the corporal tissue matrices. Mice were sacri®ced at 3 days, 1, 2, 4, 6 and 8 weeks after implantation.
Immunocytochemical and histochemical studies were performed using alpha-smooth muscle actin and Factor VIII antibodies.
Scanning electron microscopic examination of the seeded cells in vitro demonstrated a uniform attachment on the sinusoidal walls within the corporal tissue matrix. The implanted corporal tissue matrices maintained the seeded cells on the sinusoidal wall and showed host cell in®ltration three days after implantation. Formation and migration of neovasculature into the sinusoidal spaces was evident by one week after implantation. Increasing organization of smooth muscle and endothelial cells lining the sinusoidal wall was observed at two weeks and continued with time. The corporal tissue matrices were completely covered with the appropriate cell architecture four weeks after implantation. Immunocytochemical studies using alpha-actin and Factor VIII antibodies con®rmed the presence of the corporal smooth muscle and endothelial cells, both in vitro and in vivo, at all time points. There was no evidence of cellular organization in the control matrices.
This study demonstrated that human cavernosal smooth muscle and endothelial cells seeded on acellular corporal tissue matrices are able to form vascularized corporal structures in vivo. The use of these tissue matrices as cell delivery scaffolds allowed for the development of adequate structural constructs. The formation of corporal tissue, similar to that of the native erectile tissue, may provide an additional armamentarium in the management of complex penile reconstructive challenges.
To apply tissue engineering techniques to reconstruct corporal tissue clinically, further studies must be performed. These include the further development of cell delivery vehicles identical to that of native corpus cavernosal architecture, and functional and biomechanical studies of the neo-corpora. Although smooth muscle and endothelial cells are the major components of erectile tissue, other structures, such as connective tissue and nerves are needed in order to achieve normal anatomical and functional corpora. A system for engineering these tissue structures is currently being investigated in our laboratory.
Engineered clitoral tissue
The availability of clitoral smooth muscle tissue for use in females with sexual dysfunction may be of clinical utility. Primary cultures of human clitoral smooth muscle cells were derived from operative biopsies obtained during genitoplasty. Cells were maintained in culture for a period of 75 days after the ®rst passage, during which time they multiplied into multilayered`tissue-like' structures which were readily lifted off the culture plate as a stretchable layer. The layers of clitoral muscle were divided and 
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implanted subcutaneously in athymic mice. Animals were sacri®ced at 7, 14, 21, 42, and 84 days after surgery. Implants were examined histologically with hematoxylin and eosin and Masson's trichrome staining, as well as immunohistochemically with antibodies to the intermediate ®laments alphasmooth muscle actin and desmin. Morphological analysis of the`neo-tissue' in culture via phase contrast microscopy revealed characteristic spindle shaped smooth muscle cells growing on top of each other in the typical`hill and valley appearance'. Tissue specimen analyzed prior to implantation demonstrated the presence of an extracellular matrix as well as positive staining for the intermediate ®laments alpha-smooth muscle actin and desmin. Seven days after implantation, intact multilayered smooth muscle strips were identi®ed with evidence of early vascular in-growth at the periphery of the tissue. By 21 days post implantation, there was evidence of more extensive neovascularization and the smooth muscle maintained its multilayered architecture. The specimens remained immunohistochemically positive for alphasmooth muscle actin and desmin post implantation.
This study shows, for the ®rst time, that surgically obtained clitoral smooth muscle may be cultured in vitro, expanded, and developed into multilayered sheets of muscle tissue which can be retransplanted into the in vivo environment. Tissue transplants are neovascularized, and can survive in vivo, maintaining smooth muscle phenotype and architecture. The data provides evidence supporting the possibility of using autologous clitoral smooth muscle for patients with erectile dysfunction.
Engineered penile prostheses
Although silicone is an accepted biomaterial for penile prostheses, biocompatibility is a concern. 6, 7 The use of a natural prosthesis composed of autologous cells may be advantageous. A feasibility study for creating natural penile prostheses made of cartilage was performed initially. 26 Cartilage, harvested from the articular surface of calf shoulders, were isolated, grown and expanded in culture. The cells were seeded onto pre-formed cylindrical polyglycolic acid polymer rods (1 cm in diameter and 3 cm in length). The cell±polymer scaffolds were implanted in the subcutaneous space of 20 athymic mice. Each animal had two implantation sites consisting of a polymer scaffold seeded with chondrocytes and a control (polymer alone). The rods were retrieved at 1, 2, 4 and 6 months post implantation. Biomechanical properties, including compression, tension and bending were measured on the retrieved structures. Histological analyses were performed to con®rm the cellular composition.
At retrieval, all of the polymer scaffolds seeded with cells formed milky-white rod-shaped solid cartilaginous structures, maintaining their pre-implantation size and shape (Figure 3) . The control scaffolds without cells failed to form cartilage. There was no evidence of erosion, in¯ammation or infection in any of the implanted cartilage rods.
The compression, tension and bending studies showed that the cartilage structures were readily elastic and could withstand high degrees of pressure. Biomechanical analyses showed that the engineered cartilage rods possessed the mechanical properties required to maintain penile rigidity. The compression studies showed that the cartilage rods were able to withstand high degrees of pressure. A ramp compression speed of 200 mm/s, applied to each cartilage rod up to 2000 mm in distance, resulted in 3.8 kg of resistance. The tension relaxation studies demonstrated that the retrieved cartilage rods were able to withstand stress and were able to return to their initial state while maintaining their biomechanical properties. A ramp tension speed of 200 mm/s applied to each cartilage rod created a tensile strength of 2.2 kg, which physically lengthened the rods by an average of 0.48 cm. Relaxation of tension at the same speed resulted in retraction of the cartilage rods to their initial state. The bending studies performed at two different speeds showed that the engineered cartilage rods were durable, malleable, and were able to retain their mechanical properties. Cyclic compression, performed at rates of 500 mm/s and 20 000 mm/s, demonstrated that the cartilage rods could withstand up to 3.5 kg of pressure at a predetermined distance of 5000 mm. The relaxation phase of the cyclic compression studies showed that the engineered rods were able to maintain their tensile strength. None of the rods were ruptured during the biomechanical stress relaxation studies.
Histological examination with hematoxylin and eosin showed the presence of mature and well-formed cartilage in all the chondrocyte±polymer implants. The polymer ®bers were progressively replaced by cartilage with time progression. Undegraded polymer ®bers were observed at one and two months after implantation. However, remnants of polymer scaffolds were not present in the cartilage rods at six months. Aldehyde fuschin±alcian blue and toluidine blue staining demonstrated the presence of highly sulfated mucopolysaccharides which are differentiated products of chondrocytes. There was no evidence of cartilage formation in the controls.
In a subsequent study using an autologous system, the feasibility of applying the engineered cartilage rods in situ was investigated. 27 Autologous chondrocytes harvested from rabbit ear were grown and expanded in culture. The cells were seeded onto biodegradable poly-L-lactic acid coated polyglycolic acid polymer rods at a concentration of 50Â10 6 chondrocytes/cm 3 . Eighteen chondrocyte± polymer scaffolds were implanted into the corporal spaces of ten rabbits. As controls, two corpora, one Tissue engineering for erectile dysfunction A Atala each in two rabbits, were not implanted. The animals were sacri®ced at 1, 2, 3 and 6 months after implantation. Histological analyses were performed with hematoxylin and eosin, aldehyde fuschin± alcian blue, and toluidine blue staining. All animals tolerated the implants for the duration of the study without any complications. Gross examination at retrieval showed the presence of well-formed milky white cartilage structures within the corpora at one month. All polymers were fully degraded by two months. There was no evidence of erosion or infection in any of the implant sites. Histological analyses with alcian blue and toluidine blue staining demonstrated the presence of mature and well formed chondrocytes in the retrieved implants. Autologous chondrocytes seeded on pre-formed biodegradable polymer structures are able to form cartilage structures within the rabbit corpus cavernosum. This technology appears to be useful for the creation of autologous penile prostheses.
Initial studies, performed in our laboratory, showed that chondrocytes suspended in biodegradable polymers form cartilage structures when implanted in vivo. 28, 29 Currently, this technology is under FDA-sanctioned clinical trials for the treatment of urinary incontinence and vesicoureteral re¯ux. 30 In a similar manner, autologous cartilage tissue, made of the patient's own cells, could be used intracorporally for erectile dysfunction. However, in order to be able to engineer cartilage penile rods for clinical use, further studies must be conducted, including the establishment of functional and biomechanical parameters of the prostheses in vivo. Studies involving these tissues are currently being pursued in our laboratory.
Future direction
The evolution of the science of tissue engineering has allowed new approaches for the reconstruction of genital tissues. Engineering efforts, focused on creating genital structures, have been pursued for several years. These studies suggest that the reconstitution of other components of genital tissue may also be achieved in the future. One could envision using this system to treat patients with severe forms of erectile dysfunction. Small penile tissue biopsies could be obtained through minimally invasive techniques under local anesthesia. The autologous cells could be isolated, pre-selected for a normal phenotype, cloned and expanded in culture. The cells could be seeded on pre-con®gured polymer scaffolds, engineered in vitro, and implanted back into the host. It may also be possible to deliver speci®c genes regulating ®brosis and in¯ammation to the newly formed tissues using already established gene delivery methods. Tissue engineering for erectile dysfunction A Atala S46
